MAPT and frontotemporal dementia: The aim of the current study was to examine the binding of the tau PET tracer [18F]RO948 in FTD in a large sample of the heterogenous molecular pathologies underlying the syndrome of FTD, enriched with cases with a strong clinicopathological relationship.